eszopiclone

Generic: eszopiclone

Labeler: asclemed usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name eszopiclone
Generic Name eszopiclone
Labeler asclemed usa, inc.
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

eszopiclone 2 mg/1

Manufacturer
Asclemed USA, Inc.

Identifiers & Regulatory

Product NDC 76420-024
Product ID 76420-024_2df4e9b7-6d0c-7409-e063-6294a90a46ce
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA202929
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2015-01-31

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 76420024
Hyphenated Format 76420-024

Supplemental Identifiers

RxCUI
485440 485442 485465
UNII
UZX80K71OE

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name eszopiclone (source: ndc)
Generic Name eszopiclone (source: ndc)
Application Number ANDA202929 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 100 TABLET, FILM COATED in 1 BOTTLE (76420-024-01)
  • 10 TABLET, FILM COATED in 1 BOTTLE (76420-024-10)
  • 20 TABLET, FILM COATED in 1 BOTTLE (76420-024-20)
  • 30 TABLET, FILM COATED in 1 BOTTLE (76420-024-30)
  • 60 TABLET, FILM COATED in 1 BOTTLE (76420-024-60)
  • 90 TABLET, FILM COATED in 1 BOTTLE (76420-024-90)
source: ndc

Packages (6)

Ingredients (1)

eszopiclone (2 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2df4e9b7-6d0c-7409-e063-6294a90a46ce", "openfda": {"unii": ["UZX80K71OE"], "rxcui": ["485440", "485442", "485465"], "spl_set_id": ["10175591-c1b4-461a-830e-8df982d0d2bf"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (76420-024-01)", "package_ndc": "76420-024-01", "marketing_start_date": "20200617"}, {"sample": false, "description": "10 TABLET, FILM COATED in 1 BOTTLE (76420-024-10)", "package_ndc": "76420-024-10", "marketing_start_date": "20200617"}, {"sample": false, "description": "20 TABLET, FILM COATED in 1 BOTTLE (76420-024-20)", "package_ndc": "76420-024-20", "marketing_start_date": "20200617"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (76420-024-30)", "package_ndc": "76420-024-30", "marketing_start_date": "20200617"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (76420-024-60)", "package_ndc": "76420-024-60", "marketing_start_date": "20200617"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (76420-024-90)", "package_ndc": "76420-024-90", "marketing_start_date": "20200617"}], "brand_name": "Eszopiclone", "product_id": "76420-024_2df4e9b7-6d0c-7409-e063-6294a90a46ce", "dosage_form": "TABLET, FILM COATED", "product_ndc": "76420-024", "dea_schedule": "CIV", "generic_name": "Eszopiclone", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Eszopiclone", "active_ingredients": [{"name": "ESZOPICLONE", "strength": "2 mg/1"}], "application_number": "ANDA202929", "marketing_category": "ANDA", "marketing_start_date": "20150131", "listing_expiration_date": "20261231"}